Skip to content

Dr. Aimen Arij

KLOW and Skin Elasticity: What the Evidence Actually Shows

KLOW is a fixed-ratio, four-peptide research blend that pairs one skin-remodeling copper peptide with three tissue-repair and anti-inflammatory peptides in a single…

Melanotan II and Melanin: How Tanning Works, and the Risks

Melanotan II is a synthetic, cyclic analog of alpha-melanocyte-stimulating hormone (α-MSH) that has become one of the most talked-about — and most…

What Does Research Say About Sermorelin’s Role in Stimulating Natural Growth Hormone?

Yes — sermorelin raises the body’s own growth hormone, and that part of the marketing is pharmacologically correct. It is a synthetic…

What Does GHK-Cu Do for Skin Health, Wrinkle Reduction, and Collagen Synthesis?

GHK-Cu reliably increases collagen production in cultured skin cells — that part of the evidence is strong and has been reproduced since…

How NAD+ 500mg Influences Cellular Damage Repair and Longevity in Human Studies?

Short answer: there is no established 500 mg human dose of NAD+, and no trial has shown that any NAD+ product repairs…

What Are the Key Findings on Retatrutide for Managing Obesity and Metabolic Health?

Retatrutide 12 mg produced a mean weight reduction of about 28% at 80 weeks in the pivotal phase 3 TRIUMPH-1 obesity trial,…

What Research Says Regarding BPC 157 Healing Effects on the Gut and Inflammation?

The question in the title carries an assumption worth pausing on before we chase the evidence: it presumes there is a settled…

What Evidence Shows TB-500 Effectiveness in Tendon and Ligament Repair Post-Injury?

The question as posed — what evidence shows TB-500’s effectiveness in tendon and ligament repair after injury — carries a quiet assumption…

Grow-H (CJC-1295 + Ipamorelin): What the Research Shows

No clinical trial has ever tested the Grow-H blend. Grow-H is not a studied therapeutic: it is a commercial pairing of two…

How PT-141 Supports Enhancing Sexual Desire and Sperm Performance in Clinical Trials?

PT-141 (bremelanotide) is FDA-approved for exactly one thing: acquired, generalized hypoactive sexual desire disorder in premenopausal women, sold as Vyleesi.1 No trial…